IT & Software News Recombinant, MAVERIC to develop GenISIS PBR Staff Writer

Recombinant Data, a provider of data warehousing and clinical intelligence solutions, has collaborated with the US Department of Veterans Affairs (VA)'s Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), for the development of the Genomic Informatics System for Integrative Science (GenISIS) under VA's Million Veteran Program (MVP).

In working with the MAVERIC team, Recombinant uses its Agile Iterative Development approach to design and prototyping, and delivering production systems in a just-in-time mode to meet the project's requirements.

The collaboration aims to create a system to streamline and integrate key elements of recruitment and enrollment of patients for GenISIS and MVP-communicating with veterans via mail and telephone call centers regarding MVP participation; scheduling research-related appointments in coordination with schedules maintained in VistA (Veterans Health Information Systems and Technology Architecture).

VistA is VA's electronic medical record system; collecting and managing patients' research consent and initial clinical trial questionnaire data; and tracking tissue samples collected as part of the research enrollment process.

Recombinant Data CEO Peter Emerson said GenISIS is a project that many other healthcare providers are looking to emulate, as it establishes a model for secure and efficient analysis of consented genotypic data to move towards the promise of genomics to deliver personalized medicine.

Recombinant and MAVERIC are continuing to work together on the next phases of GenISIS, which will include the clinical data warehouse integrating genomic data with the clinical data maintained in the VistA EMR, biorepository management, cohort discovery and hypothesis testing tools, and the genomics analysis framework.